Who owns ONCOCYTE CORPORATION COM?

Tip: Access positions for across all investors

Analyze quarterly positions in Oncocyte Corporation with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Oncocyte Corporation stock

Who bought or sold ONCOCYTE CORPORATION COM this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 248k $620k 3% Dec 2023
 View chart
UBS Group 1.4k $3.4k 35% Dec 2023
 View chart
Royal Bank of Canada 901.00 $2.0k -12% Dec 2023
 View chart
Pnc Financial Services 500.00 $1.3k 0% Dec 2023
 View chart
Bank of America Corporation 216.00 $540.496800 3% Dec 2023
 View chart
Jpmorgan Chase & Co 154.00 $381.997000 0% Dec 2023
 View chart
Nbc Securities 150.00 $1.0k 100% Mar 2024
 View chart
Advisor Group Holdings 97.00 $241.471800 -92% Dec 2023
 View chart
Rhumbline Advisers 66.00 $163.996800 0% Dec 2023
 View chart
Wells Fargo & Company 60.00 $150.000000 3% Dec 2023
 View chart
Riggs Asset Managment 50.00 $125.000000 0% Dec 2023
 View chart
Piscataqua Savings Bank 25.00 $62.000000 0% Dec 2023
 View chart
Coppell Advisory Solutions 10.00 $25.000000 100% Dec 2023
 View chart
Albion Financial Group 7.00 $17.999800 0% Dec 2023
 View chart
Lindbrook Capital 4.00 $10.000000 0% Dec 2023
 View chart

Who sold out of Oncocyte Corporation?

Fund or Company Name Date Sold Shares Held Valued At
Millennium Management Sep 2023 15k $48k
Capital Advisors Sep 2023 61.00 $0
Us Bancorp Sep 2023 25.00 $78.000000
Meeder Asset Management Sep 2023 9.00 $27.999900